Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog

Reproductive Freedom for All Foundation (National Office)

CharityWatch rating issued
April 2025

 
CharityWatch Rating
risk WARNING: See Analysts’ Notes
 

Contact Information

Reproductive Freedom for All Foundation (National Office)
1725 Eye Street NW
Suite 900
Washington, DC 20006

Other Names

NARAL Pro-Choice America Foundation (National Office)

Tax Status

501(c)3

Stated Mission

To operate for the benefit of, and to perform the educational & charitable functions of, NARAL Pro-Choice America. Performs in-depth research & legal work, publishes substantive policy reports, mounts public education campaigns, and provides leadership training for grassroots activists.

View similar charities
Data based on Fiscal Year Ended 09/30/2023

*Why a Question Mark Rating?

CharityWatch currently has concerns about this organization and/or is unable to provide complete rating information due to the organization's nondisclosure of financial information. Please see the Analysts' Notes section for a more detailed explanation.


Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
Reproductive Freedom for All Foundation (National Office)
meets governance benchmarks.
 
Reproductive Freedom for All Foundation (National Office)
does not meet transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy No Sharing  

  Name Title Compensation
1 Rukmini Timaraju President / CEO $444,089
2 Melissa Schwartz Managing Director $349,109
3 Steven J. Kravitz Chief Financial Officer $307,606
1
Name: Rukmini Timaraju
Title: President / CEO
Compensation: $444,089
2
Name: Melissa Schwartz
Title: Managing Director
Compensation: $349,109
3
Name: Steven J. Kravitz
Title: Chief Financial Officer
Compensation: $307,606

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

CharityWatch is unable to provide a letter grade rating of Reproductive Freedom for All Foundation (the Foundation) at this time due to our specific concerns about the charity's financial reporting. For this reason we have assigned it a "?" rating for its 2023 fiscal year based on our analysis of the organization's IRS Tax Form 990 and audited financial statements for that period. Specifically, CharityWatch is concerned that the charity could be including certain fundraising expenses in its reported program expenses. 

CharityWatch contacted the Foundation on March 10, 2025, via U.S. mail with questions about its financial reporting for its fiscal year ended September 30, 2023.

In reference to page 53 of the Foundation's IRS tax Form 990, CharityWatch requested a breakout by vendor reflecting how payments to "A/B Partners PBC" and "Ward Circle Strategies, Inc." were allocated by function and natural classification in 990 Part IX, Statement of Functional Expenses. Furthermore, CharityWatch requested breakouts by function to provide clarification on whether the $2,189,122 and $949,751 of Other Professional Fees (line 11g) and Advertising and Promotion (line 12), respectively, that were allocated to Program expenses consisted of Joint Costs and/or contained any fundraising components

As of the date of this note, March 30, 2025, we have not yet received a response. If the Foundation provides an adequate response to the above questions in the future, CharityWatch may update the Foundation's fiscal 2023 rating at that time.

CharityWatch's rating of Reproductive Freedom for all Foundation is for the 501(c)(3) public charity entity (tax ID #52-1100361). CharityWatch provides a separate rating for the related 501(c)(4) tax-exempt, social welfare organization, Reproductive Freedom for All (tax ID #13-2630359).

CharityWatch separates the ratings for 501(c)(3) & 501(c)(4) organizations, even when their financial activities are included together in a consolidated audit, due to their differing treatments under the IRS tax code. For more information on this topic, please see our sections on Types of Non-Profits, Tax Status, and Treatment of Related Organizations, which can be found on the Our Process page.

For more information about things to consider when donating to organizations that have related public charity and social welfare entities, read "Sorting Out Nonprofit Pairs."

According to the Reproductive Freedom for All Foundation (the Foundation) 2023 tax filing re: "Describe on Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year," the Foundation reports:

"The organization makes some of its governing documents and financial statements available to the public. Inspections are available via an appointment at the headquarters." (IRS Form 990, Schedule O re: Form 990, Part VI, Section C, line 19).


Related External Articles